Development of zinc chelators with protein specificity aiming at molecular target therapy of cancer
Development of zinc chelators with protein specificity aiming at molecular target therapy of cancer
批准号:
17390030
负责人:
OTSUKA Masami
金额:
$10.12万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007
中文摘要
本研究旨在通过锌络合剂和蛋白质识别部分相结合的方法设计锌蛋白抑制剂。我们感兴趣的是法尼基转移酶和ADAM家族蛋白水解酶作为锌蛋白的抑制物。法尼基转移酶抑制剂的合成研究一种锌蛋白法尼基转移酶催化癌基因产物RAS的法尼化,从而诱导RAS的致癌功能。本研究的目的是在含有吡啶和半胱胺侧链的锌络合剂中引入法尼基磷酸,以获得抑制剂。考虑到法尼基的不稳定性,首次合成了4-氨基吡啶螯合剂。然后通过4-氨基和法尼基磷酸之间的磷酸酰胺键成功地引入了法尼基部分。ADAM家族蛋白酶抑制剂的合成研究已知与癌细胞的增殖、侵袭和转移密切相关的黏附分子CD44。细胞黏附和细胞运动是由于ADAM家族的蛋白水解酶对CD44胞外区的裂解,导致肿瘤的转移和侵袭。本研究使用ADAM 30的抑制剂marimastat作为ADAM家族的蛋白酶识别部分。因此,(D)-酒石酸盐被转化为相应的依波糖苷,并引入异丁基,以获得关键中间体,即马拉马司他前体。尝试了这样得到的marimastat部分与锌络合剂的偶联。
英文摘要
The present research aims at the development of inhibitors of zinc proteins designed by combing a zinc chelator and a protein recognition moiety. We were interested farnesyltransferase and ADAM family protease as zinc proteins to be inhibited.Synthetic study of farnesyltransferase inhibitorsA zinc protein farnesyltransferase catalyzes the farnesylation of an oncogene product Ras to induce the oncogenic function of Ras. The objective of the present study is to obtain inhibitors by introducing a farnesyl phosphate, a farnesyltransferase-recognition moiety, into a zinc chelator comprising a pyridine and cysteamine side chains.Considering the instability of the farnesyl group, a 4-aminopyridine chelator was first synthesized. The farnesyl moiety was then successfully introduced by the formation of phosphoramide linkage between the 4-amino group and farnesyl phosphate.Synthetic study of ADAM family protease inhibitorsAdhesive molecule CD44 is known to be closely related to proliferation, invasion and metastasis of cancer cells. The cell adhesion and the cell movement are due to the cleavage of the extracellular domain of the CD44 by ADAM family proteases, resulting the cancer metastasis and invasion.The present study employed marimastat, an ADAM 30 inhibitor, as the ADAM family protease recognition moiety. Thus (D)-Tartrate was converted into the corresponding eposide and an isobutyl group was introduced to obtain a key intermediate, a marimastat precursor. The coupling of the marimastat moiety thus obtained and the zinc chelator was attempted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Vpx is critical for the reverse transcription of human immunodeficiency virus type 2 genome in macrophages
Vpx 对于巨噬细胞中人类免疫缺陷病毒 2 型基因组的逆转录至关重要
DOI:
--
发表时间:
2008
期刊:
Journal of Virology (in press)
影响因子:
--
作者:
[Fujita, M.]
通讯作者:
M.
Inhibitory activities against topoisomerase I & II by isoaurostatin derivatives and their asructure-activity relationship
对拓扑异构酶 I 的抑制活性
DOI:
--
发表时间:
2005
期刊:
Bioorg. Med. Chem. Lett. 15 (8)
影响因子:
--
作者:
[Keitarou, Suzuki]
通讯作者:
Suzuki
Design and synthesis of biotinylated inositol phosphates relevant to thebiotin-avidin technioues
与生物素-亲和素技术相关的生物素化磷酸肌醇的设计与合成
DOI:
--
发表时间:
2008
期刊:
Org. Biomol. Chem 6
影响因子:
--
作者:
[Kensaku, Anraku]
通讯作者:
Anraku
Vpx is critical for the reversetranscription of human immunodeficiency virus type2 aenome in macrophages
Vpx 对于巨噬细胞中人类免疫缺陷病毒 2 型基因组的逆转录至关重要
DOI:
--
发表时间:
期刊:
J.Virology
影响因子:
--
作者:
[野水基義, 他5名, Mikako Fujita]
通讯作者:
Mikako Fujita
Synthesis of New Peptide Nucleic Acid Monomer with Glycylglycine Backbone.
具有甘氨酰甘氨酸骨架的新型肽核酸单体的合成。
DOI:
10.1002/chin.200701204
发表时间:
2007
期刊:
影响因子:
--
作者:
[T. Yamasaki, Mohamed Abdel, T. Iwashita, A. Watanabe, M. Sakamoto, M. Otsuka]
通讯作者:
M. Otsuka
共 16 条
Design and synthesis of anti-brain tumor and brain-protective drugs using brain-targeting peptides
-
批准号:24659048
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:OTSUKA Masami
-
依托单位:
Development of medicinal molecules having biologically functions targeting the PI3K/Akt pathway and the TGF-b/Smad pathway
-
批准号:23390028
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2011
-
负责人:OTSUKA Masami
-
依托单位:
Design and synthesis of anti-HIV agents that inhibit the Vif-mediated proteasome degradation of APOBEC3G
-
批准号:22659024
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.89万
-
财政年份:2010
-
负责人:OTSUKA Masami
-
依托单位:
Design of DNA-cleaving and -crosslinking agents based on NFκB and HMGA proteins aiming at the application to cancer therapy
-
批准号:20390033
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2008
-
负责人:OTSUKA Masami
-
依托单位:
Molecular design of anti-AIDS drugs targeting the viral and host zinc proteins
-
批准号:15390038
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:2003
-
负责人:OTSUKA Masami
-
依托单位:
Molecular design of anti-AIDS drugs targeting the human transcription machinery employed for the replication of AIDS virus
-
批准号:12557219
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:2000
-
负责人:OTSUKA Masami
-
依托单位:
Molecular Design of Ras Farnesyltransferase Inhibitors
-
批准号:11694297
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.82万
-
财政年份:1999
-
负责人:OTSUKA Masami
-
依托单位:
Development of compounds for multiple regulation of intracellular signaling
-
批准号:11470496
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.22万
-
财政年份:1999
-
负责人:OTSUKA Masami
-
依托单位:
Molecular design and synthesis of anti-cancer compounds that cause apoptosis
-
批准号:09672280
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:OTSUKA Masami
-
依托单位:
海外基金